Instead of eliminating drug rebates, use average sales price to set co-insurance levels
Changing key elements of the US health care system can be effective, but it can also be ill-advised. In January 2019, President Trump proposed a sweeping...
With new technologies driving step changes in biopharma, we can help you predict and plan for the next round of disruptive changes.